BRAQUE: Bayesian reduction for amplified quantization in UMAP embedding
Single-cell biology has revolutionized the way we understand biological processes. In this
paper, we provide a more tailored approach to clustering and analyzing spatial single-cell …
paper, we provide a more tailored approach to clustering and analyzing spatial single-cell …
Validation of an Organ Mapping Antibody Panel for Cyclical Immunofluorescence Microscopy on Normal Human Kidneys
M Brewer, LG Migas, KA Clouthier… - American Journal …, 2024 - journals.physiology.org
The lack of standardization in antibody validation remains a major contributor to
irreproducibility of human research. To address this, we have applied a standardized …
irreproducibility of human research. To address this, we have applied a standardized …
Rejuvenated vintage tissue sections highlight individual antigen fate during processing and long-term storage
F Mascadri, MM Bolognesi, D Pilla… - … of Histochemistry & …, 2021 - journals.sagepub.com
Antigen-bearing proteins become progressively unavailable to immunodetection after
prolonged storage of routine sections, exposed to a variety of agents, such as moisture …
prolonged storage of routine sections, exposed to a variety of agents, such as moisture …
A DNA damage response‐like phenotype defines a third of colon cancers at onset
S Mauro, MM Bolognesi, N Villa, G Capitoli… - The FASEB …, 2023 - Wiley Online Library
Colon adenocarcinoma (COAD) has a limited range of diversified, personalized therapeutic
opportunities, besides DNA hypermutating cases; thus, both new targets or broadening …
opportunities, besides DNA hypermutating cases; thus, both new targets or broadening …
Seeing or believing in hyperplexed spatial proteomics via antibodies: New and old biases for an image-based technology
Hyperplexed in-situ targeted proteomics via antibody immunodetection (ie,> 15 markers) is
changing how we classify cells and tissues. Differently from other high-dimensional single …
changing how we classify cells and tissues. Differently from other high-dimensional single …
A DNA damage response-like phenotype defines a novel subset of colon cancer
S Mauro, M Bolognesi, N Villa, G Capitoli, L Furia… - 2022 - researchsquare.com
Colon adenocarcinoma (COAD) has a limited range of diversified, personalized therapeutic
opportunities, besides DNA hypermutating cases; thus both new targets or broadening …
opportunities, besides DNA hypermutating cases; thus both new targets or broadening …